- A study from the University of Oxford examined semaglutide, a medication used to treat type 2 diabetes and obesity, better known under the brand names Ozempic or Wegovy.
- The researchers wanted to find out whether semaglutide causes neurological or psychological issues in people who are prescribed semaglutide for type 2 diabetes treatment.
- The study found that the medication does not contribute to an increased risk for either of these issues.
- The scientists found that semaglutide actually…
Read the full article here